Unveil Pharma
Venture capitalBoston · Pre-Seed–Series A · 1 people tracked
Find your way into Unveil Pharma
421 people in our graph share verified history with the Unveil Pharma team — schools, employers, funds. One of them is your warm intro.
Investment thesis
UNVEILpharma invests in early-stage biotech companies with curated technologies that have a clear path to exit within five years. The firm leverages world-class deal flow from academic institutions like Harvard and MIT, and provides operational value through deep expertise in drug development and commercialization.
Source: firm website, verified Aug 6, 2026.
Team · 1 people
from public directories
Frequently asked questions
- What stage does Unveil Pharma invest at?
- Unveil Pharma invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Unveil Pharma focus on?
- Unveil Pharma focuses on Biotech.
- Where is Unveil Pharma located?
- Unveil Pharma is headquartered in Boston, US.
Similar investors
Draper Associates is an early-stage venture firm that backs bold, visionary founders building transformational businesses ahead of mainstream conviction.
Kindred Capital is a London-based venture capital firm that backs early-stage founders, emphasizing a team-oriented, partnership approach to supporting companies over the long term.
SciFounders backs technical founders building science-heavy companies, investing from pre-seed to Series A. It also runs the SciFounder Fellowship offering up to $1M and hands-on mentorship.
Bantam Group is an advisory firm that for two decades has worked with entrepreneurs to help execute their ideas, typically serving as mentor, coach and advocate to founders, management teams and shareholders.
A-Level Capital is an early-stage venture fund associated with Johns Hopkins University that invests primarily in pre-seed and seed rounds, with check sizes typically ranging from $40K to $100K.